EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Pheochromocytomas and Paragangliomas

Hussam Alkaissi, David Taieb, Hans K Ghayee

Endocrinology and Metabolism Clinics of North America · 2026-06 · 55 (2) · 317-344

DOI: 10.1016/j.ecl.2026.01.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism Clinics of North America, 2026-06. Verfasst von Hussam Alkaissi und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Paraganglioma, Adrenal Gland Neoplasms, Pheochromocytoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PPGL are rare neuroendocrine tumors that secrete catecholamines. There are over 20 driver mutations associated with PPGL. All patients who have been diagnosed with PPGL need genetic testing. Diagnosis is made by checking either plasma or urine metanephrines. Localization studies include computed tomography, magnetic resonance imaging, and functional imaging such as positron emission tomography scans. Alpha-blockers are a central component for preparation prior to surgical removal of the tumor, which is the mainstay of therapy. For patients with metastatic disease, several different modalities can be employed from palliative surgery, chemotherapy, radionuclide therapy, HIF-2α inhibitor, and drugs in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ParagangliomaAdrenal Gland NeoplasmsPheochromocytomaHumans

Stichwörter der Autor:innen

CatecholaminesMetanephrinesParagangliomaPheochromocytomaPseudohypoxia

Autor:innen und Institutionen

  • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Department of Nuclear Medicine, Aix-Marseille University, La Timone University Hospital, Marseille, France.
  • Division of Endocrinology and Metabolism, Department of Medicine, University of Florida, Endocrinology and Metabolism, North Florida/South Georgia VA Health System, 1600 Southwest Archer Road, Suite H-2, Gainesville, FL…

Förderung

  • Intramural NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health
  • U.S. Department of Health and Human Services

Zitieren

APA

Alkaissi, H., Taieb, D., & Ghayee, H. K. (2026). Pheochromocytomas and Paragangliomas. Endocrinology and Metabolism Clinics of North America, 55(2), 317-344. https://doi.org/10.1016/j.ecl.2026.01.007

Vancouver

Alkaissi H, Taieb D, Ghayee HK. Pheochromocytomas and Paragangliomas. Endocrinology and Metabolism Clinics of North America. 2026;55(2):317-344. doi:10.1016/j.ecl.2026.01.007

BibTeX
@article{Alkaissi2026,
  author = {Alkaissi, Hussam and Taieb, David and Ghayee, Hans K},
  title = {Pheochromocytomas and Paragangliomas},
  journal = {Endocrinology and Metabolism Clinics of North America},
  year = {2026},
  volume = {55},
  number = {2},
  pages = {317--344},
  doi = {10.1016/j.ecl.2026.01.007}
}
Kostenlos starten →